Literature DB >> 30483822

Coexpression of FOXK1 and vimentin promotes EMT, migration, and invasion in gastric cancer cells.

Hui Zhang1,2, Xiaosheng Wu1, Yizhi Xiao1, Liqing Wu1, Ying Peng1, Weimei Tang1, Guangnan Liu1, Yong Sun1, Jing Wang1, Huiqiong Zhu1, Mengwei Liu1, Wenjing Zhang3, Weiyu Dai1, Ping Jiang1, Aimin Li1, Guoxin Li4, Li Xiang5, Side Liu6,7, Jide Wang8,9.   

Abstract

In human gastric cancer (GC), the upregulation of FOXK1 and vimentin is frequently observed in cancer cells and correlates with increased malignancy. We report that FOXK1 synergizes with vimentin to promote GC invasion and metastasis via the induction of epithelial-mesenchymal transition (EMT). We showed that higher expression levels of FOXK1 were significantly associated with GC development. FOXK1 can physically interact with and stabilize vimentin. Moreover, a positive correlation between the expression of FOXK1 and vimentin was found in GC cells. Higher expression levels of these two proteins were significantly associated with differentiation, lymph node metastasis, AJCC stage, and poorer prognosis. Furthermore, the coexpression of FOXK1 and vimentin enhances cell metastasis through the induction of EMT in GC cells. However, the siRNA-mediated repression of vimentin in FOXK1-overexpressing cells reversed the EMT-like phenotype and reduced GC cell migration and invasion in vitro and in vivo. Altogether, our findings suggest that the vimentin-FOXK1 axis provides new insights into the molecular mechanisms underlying EMT regulation during GC progression and metastasis.

Entities:  

Keywords:  Epithelial-mesenchymal transition; FOXK1; Gastric cancer; Metastasis; Vimentin

Mesh:

Substances:

Year:  2018        PMID: 30483822     DOI: 10.1007/s00109-018-1720-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  37 in total

1.  Rufy3 promotes metastasis through epithelial-mesenchymal transition in colorectal cancer.

Authors:  Ruyi Xie; Jing Wang; Weimei Tang; Yueqiao Li; Ying Peng; Hui Zhang; Guangnan Liu; Xiaoting Huang; Jinjun Zhao; Aimin Li; Wei Gong; Ye Chen; Yuexin Ren; Yadong Wang; Guoxin Li; Side Liu; Jide Wang
Journal:  Cancer Lett       Date:  2017-01-13       Impact factor: 8.679

2.  Vimentin as a tumour marker.

Authors:  K Thomas; V Mayston
Journal:  Histopathology       Date:  1987-09       Impact factor: 5.087

3.  Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.

Authors:  Jeffrey Chun Tatt Lim; Valerie Cui Yun Koh; Jane Sie Yong Tan; Wai Jin Tan; Aye Aye Thike; Puay Hoon Tan
Journal:  Breast Cancer Res Treat       Date:  2015-02-13       Impact factor: 4.872

4.  Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells.

Authors:  Chrysovalantis Andreolas; Margarita Kalogeropoulou; Angeliki Voulgari; Alexander Pintzas
Journal:  Int J Cancer       Date:  2008-04-15       Impact factor: 7.396

5.  Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.

Authors:  Y Usami; S Satake; F Nakayama; M Matsumoto; K Ohnuma; T Komori; S Semba; A Ito; H Yokozaki
Journal:  J Pathol       Date:  2008-07       Impact factor: 7.996

6.  EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.

Authors:  J Huang; D Xiao; G Li; J Ma; P Chen; W Yuan; F Hou; J Ge; M Zhong; Y Tang; X Xia; Z Chen
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

7.  The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.

Authors:  Pang-Kuo Lo; Ji Shin Lee; Xiaohui Liang; Saraswati Sukumar
Journal:  Cell Signal       Date:  2016-07-01       Impact factor: 4.315

8.  Epithelial-mesenchymal transition enhances nanoscale actin filament dynamics of ovarian cancer cells.

Authors:  Sunyoung Lee; Yang Yang; David Fishman; Mark M Banaszak Holl; Seungpyo Hong
Journal:  J Phys Chem B       Date:  2013-07-26       Impact factor: 2.991

9.  FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas.

Authors:  David Milewski; David Balli; Vladimir Ustiyan; Tien Le; Hendrik Dienemann; Arne Warth; Kai Breuhahn; Jeffrey A Whitsett; Vladimir V Kalinichenko; Tanya V Kalin
Journal:  PLoS Genet       Date:  2017-12-21       Impact factor: 5.917

10.  FOXK1 facilitates cell proliferation through regulating the expression of p21, and promotes metastasis in ovarian cancer.

Authors:  Li Li; Miao Gong; Yu Zhao; Xiujun Zhao; Quanhai Li
Journal:  Oncotarget       Date:  2017-07-31
View more
  18 in total

1.  The KN Motif and Ankyrin Repeat Domains 1/CXXC Finger Protein 5 Axis Regulates Epithelial-Mesenchymal Transformation, Metastasis and Apoptosis of Gastric Cancer via Wnt Signaling.

Authors:  Xin Chen; Xiaodong Wang; Lanjuan Yi; Ying Song
Journal:  Onco Targets Ther       Date:  2020-07-28       Impact factor: 4.147

2.  Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy.

Authors:  Yiyi Zhang; Meifang Xu; Jianhua Chen; Kui Chen; Jinfu Zhuang; Yuanfeng Yang; Xing Liu; Guoxian Guan
Journal:  Onco Targets Ther       Date:  2020-09-16       Impact factor: 4.147

3.  Forkhead box K1 facilitates growth of papillary thyroid carcinoma cells by regulating connective tissue growth factor expression.

Authors:  Hongwei Xu; Yang Liu; Zheng Liu; Xiaoming Wang; Xiubo Lu
Journal:  Hum Cell       Date:  2020-10-24       Impact factor: 4.174

4.  Vimentin immunoexpression is associated with higher tumor grade, metastasis, and shorter survival in colorectal cancer.

Authors:  Jaudah Al-Maghrabi
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

5.  Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer.

Authors:  Xiaosheng Wu; Mengwei Liu; Huiqiong Zhu; Jing Wang; Weiyu Dai; Jiaying Li; Danping Zhu; Weimei Tang; Yizhi Xiao; Jianjiao Lin; Wenjing Zhang; Yong Sun; Yi Zhang; Yaying Chen; Guoxin Li; Aimin Li; Li Xiang; Side Liu; Jide Wang
Journal:  J Exp Clin Cancer Res       Date:  2019-06-24

6.  Foxk1 regulates cancer progression.

Authors:  Daniel J Garry; Geunho Maeng; Mary G Garry
Journal:  Ann Transl Med       Date:  2020-09

7.  CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells.

Authors:  Xiaoting Huang; Leyang Xiang; Baiyao Wang; Jijie Hu; Chunshan Liu; Anbang Ren; Kunpeng Du; Gengtai Ye; Yingying Liang; Yunqiang Tang; Dinghua Yang; Yawei Yuan
Journal:  J Transl Med       Date:  2021-03-23       Impact factor: 5.531

8.  Coexpression of HOXA6 and PBX2 promotes metastasis in gastric cancer.

Authors:  Jianjiao Lin; Huiqiong Zhu; Linjie Hong; Weimei Tang; Jing Wang; Hongsong Hu; Xiaosheng Wu; Yaying Chen; Guangnan Liu; Qiong Yang; Jiaying Li; Yusi Wang; Zhizhao Lin; Yizhi Xiao; Weiyu Dai; Miaojvan Huang; Guoxin Li; Aimin Li; Jide Wang; Li Xiang; Side Liu
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

9.  Transcription factor forkhead box K1 regulates miR-32 expression and enhances cell proliferation in colorectal cancer.

Authors:  Weiyun Wu; Yongze Chen; Shicai Ye; Hui Yang; Jianyun Yang; Juanhua Quan
Journal:  Oncol Lett       Date:  2021-03-22       Impact factor: 2.967

10.  Inhibiting Forkhead box K1 induces autophagy to reverse epithelial-mesenchymal transition and metastasis in gastric cancer by regulating Myc-associated zinc finger protein in an acidic microenvironment.

Authors:  Yixuan Wang; Libin Sun; Wensheng Qiu; Weiwei Qi; Yaoyue Qi; Zhao Liu; Shihai Liu; Jing Lv
Journal:  Aging (Albany NY)       Date:  2020-04-08       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.